United-Guardian, Inc. (UG) 10-Year Financial Performance & Capital Metrics

UG • • Industrial / General

Consumer DefensiveHousehold ProductsPersonal Care & CosmeticsSkincare & Hair Care

AboutUnited-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.Show more

Revenue $12M +11.9%
EBITDA $4M +26.1%
Net Income $3M +25.9%
EPS (Diluted) 0.71 +26.8%
Gross Margin 53.03% +6.8%
EBITDA Margin 30.72% +12.6%
Operating Margin 29.94% +13.8%
Net Margin 26.69% +12.5%
ROE 27.94% +11.8%
ROIC 41.59% +12.2%
Debt/Equity -
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 26.6%
✓Strong Piotroski F-Score: 7/9
✓FCF machine: 24.9% free cash flow margin
✓Healthy 5Y average net margin of 26.8%

✗Weaknesses

✗Weak momentum: RS Rating 19 (bottom 19%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-0.99%

5Y-2.18%

3Y-4.37%

TTM-18.29%

Profit (Net Income) CAGR

10Y-2.17%

5Y-7.35%

3Y-11.3%

TTM-43.76%

EPS CAGR

10Y-2.12%

5Y-7.35%

3Y-11.08%

TTM-43.42%

ROCE

10Y Avg39.55%

5Y Avg38.1%

3Y Avg33.73%

Latest31.34%

Peer Comparison

Skincare & Hair Care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AXILAXIL Brands, Inc.	52.99M	7.79	77.90	-4.51%	3.26%	8.85%	2.9%	0.08
ULUnilever PLC	141.09B	64.70	28.25	1.94%	10.16%	61.19%	5.51%	1.36
CLColgate-Palmolive Company	66.87B	82.96	23.64	3.31%	14.47%	234.81%	5.3%	15.65
PGThe Procter & Gamble Company	337.05B	144.24	22.16	0.29%	19.74%	31.31%	4.17%	0.68
SLSNSolesence, Inc. Common Stock	107.22M	1.52	21.71	40.35%	1.72%	6.21%		1.02
EPCEdgewell Personal Care Company	861.43M	18.44	9.36	0.09%	2.94%	4.13%	20.26%	0.87
UGUnited-Guardian, Inc.	28.76M	6.26	8.82	11.91%	19.48%	18.52%	10.55%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	14.01M	10.78M	12.97M	13.77M	13.6M	10.99M	13.93M	12.7M	10.89M	12.18M
Revenue Growth %	0.04%	-0.23%	0.2%	0.06%	-0.01%	-0.19%	0.27%	-0.09%	-0.14%	0.12%
Cost of Goods Sold+	5.2M	4.88M	5.3M	5.67M	5.66M	4.87M	5.75M	6M	5.48M	5.72M
COGS % of Revenue	0.37%	0.45%	0.41%	0.41%	0.42%	0.44%	0.41%	0.47%	0.5%	0.47%
Gross Profit+	8.8M	5.89M	7.67M	8.1M	7.94M	6.11M	8.18M	6.7M	5.41M	6.46M
Gross Margin %	0.63%	0.55%	0.59%	0.59%	0.58%	0.56%	0.59%	0.53%	0.5%	0.53%
Gross Profit Growth %	0.08%	-0.33%	0.3%	0.06%	-0.02%	-0.23%	0.34%	-0.18%	-0.19%	0.2%
Operating Expenses+	2.51M	2.5M	2.43M	2.52M	2.55M	2.48M	2.51M	2.66M	2.54M	2.81M
OpEx % of Revenue	0.18%	0.23%	0.19%	0.18%	0.19%	0.23%	0.18%	0.21%	0.23%	0.23%
Selling, General & Admin	1.86M	1.85M	1.79M	2.12M	0	0	0	0	0	0
SG&A % of Revenue	0.13%	0.17%	0.14%	0.15%	-	-	-	-	-	-
Research & Development	648.21K	651.83K	646.08K	399.52K	397.39K	451.21K	478.64K	490.77K	463.99K	456.78K
R&D % of Revenue	0.05%	0.06%	0.05%	0.03%	0.03%	0.04%	0.03%	0.04%	0.04%	0.04%
Other Operating Expenses	0	0	0	0	2.15M	2.03M	2.04M	2.17M	2.08M	2.36M
Operating Income+	6.29M	3.39M	5.24M	5.58M	5.4M	3.64M	5.67M	4.04M	2.86M	3.65M
Operating Margin %	0.45%	0.31%	0.4%	0.41%	0.4%	0.33%	0.41%	0.32%	0.26%	0.3%
Operating Income Growth %	0.15%	-0.46%	0.54%	0.07%	-0.03%	-0.33%	0.56%	-0.29%	-0.29%	0.27%
EBITDA+	6.47M	3.58M	5.44M	5.77M	5.57M	3.8M	5.81M	4.17M	2.97M	3.74M
EBITDA Margin %	0.46%	0.33%	0.42%	0.42%	0.41%	0.35%	0.42%	0.33%	0.27%	0.31%
EBITDA Growth %	0.14%	-0.45%	0.52%	0.06%	-0.03%	-0.32%	0.53%	-0.28%	-0.29%	0.26%
D&A (Non-Cash Add-back)	173.48K	187.03K	200.68K	191.94K	175.81K	165.26K	145.98K	135.4K	105.68K	95.89K
EBIT	6.29M	3.39M	5.24M	5.58M	5.4M	3.64M	5.67M	4.04M	2.86M	3.65M
Net Interest Income+	0	0	0	0	203.33K	226.25K	233.86K	-1.38M	306.65K	434.68K
Interest Income	0	0	0	0	203.33K	226.25K	233.86K	236.69K	306.65K	434.68K
Interest Expense	0	0	0	227.98K	-	0	0	1.62M	0	0
Other Income/Expense	331.83K	306.5K	315.17K	-113.99K	634.4K	524.83K	210.84K	-809.55K	387.75K	461.67K
Pretax Income+	6.63M	3.7M	5.55M	5.47M	6.03M	4.16M	5.88M	3.23M	3.25M	4.11M
Pretax Margin %	0.47%	0.34%	0.43%	0.4%	0.44%	0.38%	0.42%	0.25%	0.3%	0.34%
Income Tax+	2.02M	1.11M	1.71M	1.11M	1.27M	856.02K	1.22M	658.17K	669.41K	857.58K
Effective Tax Rate %	0.7%	0.7%	0.69%	0.8%	0.79%	0.79%	0.79%	0.8%	0.79%	0.79%
Net Income+	4.61M	2.58M	3.84M	4.35M	4.76M	3.3M	4.66M	2.57M	2.58M	3.25M
Net Margin %	0.33%	0.24%	0.3%	0.32%	0.35%	0.3%	0.33%	0.2%	0.24%	0.27%
Net Income Growth %	0.14%	-0.44%	0.49%	0.13%	0.09%	-0.31%	0.41%	-0.45%	0%	0.26%
Net Income (Continuing)	4.61M	2.58M	3.84M	4.35M	4.76M	3.3M	4.66M	2.57M	2.58M	3.25M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	1.00	0.56	0.84	0.95	1.04	0.72	1.01	0.56	0.56	0.71
EPS Growth %	0.14%	-0.44%	0.5%	0.13%	0.09%	-0.31%	0.4%	-0.45%	0%	0.27%
EPS (Basic)	1.00	0.56	0.84	0.95	1.04	0.72	1.01	0.56	0.56	0.71
Diluted Shares Outstanding	4.59M	4.59M	4.59M	4.58M	4.59M	4.59M	4.59M	4.59M	4.59M	4.59M
Basic Shares Outstanding	4.59M	4.59M	4.59M	4.58M	4.59M	4.59M	4.59M	4.59M	4.59M	4.59M
Dividend Payout Ratio	1%	1.33%	1.69%	1.11%	1.06%	1.08%	1.11%	1.22%	0.18%	0.85%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	14.52M	13.97M	11.85M	11.69M	11.57M	11.25M	11.58M	9.97M	12.25M	12.67M
Cash & Short-Term Investments	11.8M	10.64M	8.45M	8.17M	7.92M	8.18M	8.17M	6.48M	9.09M	9.4M
Cash Only	1.08M	424.3K	724.72K	550.13K	1.05M	591.44K	531.21K	830.45K	8.24M	1.88M
Short-Term Investments	10.72M	10.22M	7.72M	7.62M	6.87M	7.59M	7.64M	5.65M	851.32K	7.52M
Accounts Receivable	934.75K	1.6M	1.91M	1.67M	2.1M	1.39M	1.81M	1.43M	1.57M	1.43M
Days Sales Outstanding	24.36	54.12	53.63	44.34	56.32	46.1	47.52	41.03	52.54	42.8
Inventory	1.29M	1.26M	1.34M	1.48M	1.22M	1.42M	1.41M	1.67M	1.22M	1.45M
Days Inventory Outstanding	90.77	93.88	92.3	95.46	78.54	106.06	89.59	101.78	81.5	92.63
Other Current Assets	329.07K	135.32K	157.96K	159.36K	170.47K	161.21K	0	201.85K	191.71K	207.8K
Total Non-Current Assets+	1.17M	1.15M	1M	857.57K	795.53K	673.66K	658.86K	669.71K	670.13K	1.13M
Property, Plant & Equipment	1.1M	1.09M	942.89K	827.92K	780.71K	673.66K	658.86K	559.16K	619.2K	956.39K
Fixed Asset Turnover	12.78x	9.88x	13.75x	16.63x	17.42x	16.31x	21.14x	22.71x	17.58x	12.74x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	14.82K	0	0	0	0	0
Long-Term Investments	0	0	0	0	-401.68K	0	0	0	0	0
Other Non-Current Assets	-43.89K	-192.84K	-111.7K	-223.94K	14.82K	-151.68K	-83.22K	0	0	0
Total Assets+	15.69M	15.12M	12.85M	12.54M	12.36M	11.92M	12.24M	10.64M	12.92M	13.8M
Asset Turnover	0.89x	0.71x	1.01x	1.10x	1.10x	0.92x	1.14x	1.19x	0.84x	0.88x
Asset Growth %	-0.02%	-0.04%	-0.15%	-0.02%	-0.01%	-0.04%	0.03%	-0.13%	0.21%	0.07%
Total Current Liabilities+	988.37K	1.05M	1.42M	1.37M	1.34M	1.41M	2.34M	1.37M	1.53M	1.91M
Accounts Payable	96.81K	82.82K	354.29K	186.8K	71.39K	31.8K	410.89K	30.41K	134.45K	425K
Days Payables Outstanding	6.79	6.19	24.39	12.03	4.61	2.38	26.09	1.85	8.96	27.11
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	190.16K	0	15.5K	0
Other Current Liabilities	105.93K	215.98K	314.54K	299.25K	373.94K	321.74K	898.4K	638.98K	543.85K	681.73K
Current Ratio	14.69x	13.36x	8.33x	8.55x	8.61x	7.95x	4.95x	7.26x	7.99x	6.62x
Quick Ratio	13.38x	12.15x	7.39x	7.47x	7.71x	6.95x	4.35x	6.04x	7.19x	5.86x
Cash Conversion Cycle	108.33	141.81	121.53	127.76	130.25	149.78	111.01	140.96	125.08	108.32
Total Non-Current Liabilities+	150.39K	252.13K	33.85K	253.58K	386.86K	151.68K	83.22K	0	0	0
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities	118.01K	252.13K	33.85K	253.58K	386.86K	151.68K	83.22K	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	0	0
Total Liabilities	1.14M	1.3M	1.46M	1.62M	1.73M	1.57M	2.42M	1.37M	1.53M	1.91M
Total Debt+	0	0	0	0	0	0	0	0	0	0
Net Debt	-1.08M	-424.3K	-724.72K	-550.13K	-1.05M	-591.44K	-531.21K	-830.45K	-8.24M	-1.88M
Debt / Equity	-	-	-	-	-	-	-	-	-	-
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-0.17x	-0.12x	-0.13x	-0.10x	-0.19x	-0.16x	-0.09x	-0.20x	-2.78x	-0.50x
Interest Coverage	-	-	-	24.48x	-	-	-	2.49x	-	-
Total Equity+	14.55M	13.82M	11.4M	10.92M	10.63M	10.35M	9.82M	9.27M	11.39M	11.88M
Equity Growth %	-0.01%	-0.05%	-0.18%	-0.04%	-0.03%	-0.03%	-0.05%	-0.06%	0.23%	0.04%
Book Value per Share	3.17	3.01	2.48	2.38	2.31	2.25	2.14	2.02	2.48	2.59
Total Shareholders' Equity	14.55M	13.82M	11.4M	10.92M	10.63M	10.35M	9.82M	9.27M	11.39M	11.88M
Common Stock	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K
Retained Earnings	14.02M	13.19M	10.47M	10.47M	10.17M	9.89M	9.36M	8.81M	10.93M	11.42M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	72.36K	175.63K	466.02K	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	5.2M	2.29M	3.99M	4.95M	4.48M	3.59M	5.31M	2.53M	3.14M	3.47M
Operating CF Margin %	0.37%	0.21%	0.31%	0.36%	0.33%	0.33%	0.38%	0.2%	0.29%	0.28%
Operating CF Growth %	0.16%	-0.56%	0.74%	0.24%	-0.1%	-0.2%	0.48%	-0.52%	0.25%	0.1%
Net Income	4.61M	2.58M	3.84M	4.35M	4.76M	3.3M	4.66M	2.57M	2.58M	3.25M
Depreciation & Amortization	173.48K	187.03K	200.68K	191.94K	175.81K	165.26K	145.98K	135.4K	105.68K	95.89K
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	-22.37K	59.71K	-31.76K	219.73K	133.27K	-235.17K	-68.46K	-193.77K	59.61K	-124.47K
Other Non-Cash Items	-21.24K	8.29K	-29.02K	341.65K	-411.79K	-305.75K	14.45K	1.08M	-111.49K	-43.53K
Working Capital Changes	464.68K	-546.75K	8.1K	-155.24K	-182.89K	664.92K	562.77K	-1.06M	509.3K	287.49K
Change in Receivables	679.75K	-671.53K	-311.69K	237.17K	-430.13K	717.87K	-431.88K	385.96K	-135.87K	140.71K
Change in Inventory	-56.49K	37.83K	-84.71K	-141.63K	249.87K	-198.5K	4.98K	-290.22K	465.51K	-214.28K
Change in Payables	-44.3K	-13.99K	271.46K	-167.49K	-115.41K	-39.59K	379.09K	-380.48K	104.03K	290.55K
Cash from Investing+	-1.67M	490.24K	2.82M	-308.76K	1.07M	-468.68K	-183.47K	897.56K	4.73M	-7.08M
Capital Expenditures	-62.57K	-166.69K	-38.15K	-74.99K	-113.77K	-43.4K	-116.38K	-75.18K	-165.72K	-433.08K
CapEx % of Revenue	0%	0.02%	0%	0.01%	0.01%	0%	0.01%	0.01%	0.02%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-60.18K	-167.7K	-4.85K	-70.79K	-113.77K	-43.4K	-116.38K	0	10K	0
Cash from Financing+	-4.47M	-3.44M	-6.51M	-4.82M	-5.05M	-3.58M	-5.19M	-3.12M	-459.39K	-2.76M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-4.59M	-3.44M	-6.51M	-4.82M	-5.05M	-3.58M	-5.19M	-3.12M	-459.39K	-2.76M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	120.85K	0	0	0	0	0	0	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	5.14M	2.12M	3.95M	4.88M	4.36M	3.55M	5.2M	2.45M	2.98M	3.03M
FCF Margin %	0.37%	0.2%	0.3%	0.35%	0.32%	0.32%	0.37%	0.19%	0.27%	0.25%
FCF Growth %	0.16%	-0.59%	0.86%	0.23%	-0.11%	-0.19%	0.46%	-0.53%	0.22%	0.02%
FCF per Share	1.12	0.46	0.86	1.06	0.95	0.77	1.13	0.53	0.65	0.66
FCF Conversion (FCF/Net Income)	1.13x	0.89x	1.04x	1.14x	0.94x	1.09x	1.14x	0.98x	1.22x	1.07x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	1.6M	1.15M	1.1M	1.02M	1.1M	1.13M	600K	1.05M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	31.46%	18.2%	30.49%	39%	44.18%	31.5%	46.18%	26.92%	24.99%	27.94%
Return on Invested Capital (ROIC)	36.06%	18.93%	32.63%	39.77%	40.55%	28.19%	44.62%	34.16%	37.08%	41.59%
Gross Margin	62.86%	54.69%	59.12%	58.84%	58.4%	55.65%	58.74%	52.78%	49.66%	53.03%
Net Margin	32.89%	23.95%	29.64%	31.61%	35.01%	30.08%	33.44%	20.23%	23.71%	26.69%
Interest Coverage	-	-	-	24.48x	-	-	-	2.49x	-	-
FCF Conversion	1.13x	0.89x	1.04x	1.14x	0.94x	1.09x	1.14x	0.98x	1.22x	1.07x
Revenue Growth	4.14%	-23.06%	20.33%	6.18%	-1.24%	-19.21%	26.79%	-8.84%	-14.28%	11.91%

Revenue by Segment

	2012	2013	2014	2015	2016
Personal Care	9.44M	11.46M	9.42M	9.92M	4.92M
Personal Care Growth	-	21.41%	-17.79%	5.32%	-50.45%
Pharmaceuticals	1.52M	916.93K	1.69M	1.86M	3.44M
Pharmaceuticals Growth	-	-39.86%	83.94%	10.53%	84.71%
Medical	2.9M	3.03M	2.49M	2.2M	2.62M
Medical Growth	-	4.28%	-17.65%	-11.64%	19.09%
Industrial And Other	153.5K	164.01K	169.49K	174.36K	159.94K
Industrial And Other Growth	-	6.85%	3.34%	2.88%	-8.27%

Frequently Asked Questions

Valuation & Price

United-Guardian, Inc. (UG) has a price-to-earnings (P/E) ratio of 8.8x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

United-Guardian, Inc. (UG) reported $10.1M in revenue for fiscal year 2024. This represents a 30% decrease from $14.3M in 2011.

United-Guardian, Inc. (UG) grew revenue by 11.9% over the past year. This is steady growth.

Yes, United-Guardian, Inc. (UG) is profitable, generating $2.0M in net income for fiscal year 2024 (26.7% net margin).

Dividend & Returns

Yes, United-Guardian, Inc. (UG) pays a dividend with a yield of 9.58%. This makes it attractive for income-focused investors.

United-Guardian, Inc. (UG) has a return on equity (ROE) of 27.9%. This is excellent, indicating efficient use of shareholder capital.

United-Guardian, Inc. (UG) generated $1.6M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

United-Guardian, Inc. (UG) 10-Year Financial Performance & Capital Metrics

UG • • Industrial / General

Consumer DefensiveHousehold ProductsPersonal Care & CosmeticsSkincare & Hair Care

Revenue $12M +11.9%
EBITDA $4M +26.1%
Net Income $3M +25.9%
EPS (Diluted) 0.71 +26.8%
Gross Margin 53.03% +6.8%
EBITDA Margin 30.72% +12.6%
Operating Margin 29.94% +13.8%
Net Margin 26.69% +12.5%
ROE 27.94% +11.8%
ROIC 41.59% +12.2%
Debt/Equity -
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 26.6%
✓Strong Piotroski F-Score: 7/9
✓FCF machine: 24.9% free cash flow margin
✓Healthy 5Y average net margin of 26.8%

✗Weaknesses

✗Weak momentum: RS Rating 19 (bottom 19%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-0.99%

5Y-2.18%

3Y-4.37%

TTM-18.29%

Profit (Net Income) CAGR

10Y-2.17%

5Y-7.35%

3Y-11.3%

TTM-43.76%

EPS CAGR

10Y-2.12%

5Y-7.35%

3Y-11.08%

TTM-43.42%

ROCE

10Y Avg39.55%

5Y Avg38.1%

3Y Avg33.73%

Latest31.34%

Peer Comparison

Skincare & Hair Care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AXILAXIL Brands, Inc.	52.99M	7.79	77.90	-4.51%	3.26%	8.85%	2.9%	0.08
ULUnilever PLC	141.09B	64.70	28.25	1.94%	10.16%	61.19%	5.51%	1.36
CLColgate-Palmolive Company	66.87B	82.96	23.64	3.31%	14.47%	234.81%	5.3%	15.65
PGThe Procter & Gamble Company	337.05B	144.24	22.16	0.29%	19.74%	31.31%	4.17%	0.68
SLSNSolesence, Inc. Common Stock	107.22M	1.52	21.71	40.35%	1.72%	6.21%		1.02
EPCEdgewell Personal Care Company	861.43M	18.44	9.36	0.09%	2.94%	4.13%	20.26%	0.87
UGUnited-Guardian, Inc.	28.76M	6.26	8.82	11.91%	19.48%	18.52%	10.55%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	14.01M	10.78M	12.97M	13.77M	13.6M	10.99M	13.93M	12.7M	10.89M	12.18M
Revenue Growth %	0.04%	-0.23%	0.2%	0.06%	-0.01%	-0.19%	0.27%	-0.09%	-0.14%	0.12%
Cost of Goods Sold+	5.2M	4.88M	5.3M	5.67M	5.66M	4.87M	5.75M	6M	5.48M	5.72M
COGS % of Revenue	0.37%	0.45%	0.41%	0.41%	0.42%	0.44%	0.41%	0.47%	0.5%	0.47%
Gross Profit+	8.8M	5.89M	7.67M	8.1M	7.94M	6.11M	8.18M	6.7M	5.41M	6.46M
Gross Margin %	0.63%	0.55%	0.59%	0.59%	0.58%	0.56%	0.59%	0.53%	0.5%	0.53%
Gross Profit Growth %	0.08%	-0.33%	0.3%	0.06%	-0.02%	-0.23%	0.34%	-0.18%	-0.19%	0.2%
Operating Expenses+	2.51M	2.5M	2.43M	2.52M	2.55M	2.48M	2.51M	2.66M	2.54M	2.81M
OpEx % of Revenue	0.18%	0.23%	0.19%	0.18%	0.19%	0.23%	0.18%	0.21%	0.23%	0.23%
Selling, General & Admin	1.86M	1.85M	1.79M	2.12M	0	0	0	0	0	0
SG&A % of Revenue	0.13%	0.17%	0.14%	0.15%	-	-	-	-	-	-
Research & Development	648.21K	651.83K	646.08K	399.52K	397.39K	451.21K	478.64K	490.77K	463.99K	456.78K
R&D % of Revenue	0.05%	0.06%	0.05%	0.03%	0.03%	0.04%	0.03%	0.04%	0.04%	0.04%
Other Operating Expenses	0	0	0	0	2.15M	2.03M	2.04M	2.17M	2.08M	2.36M
Operating Income+	6.29M	3.39M	5.24M	5.58M	5.4M	3.64M	5.67M	4.04M	2.86M	3.65M
Operating Margin %	0.45%	0.31%	0.4%	0.41%	0.4%	0.33%	0.41%	0.32%	0.26%	0.3%
Operating Income Growth %	0.15%	-0.46%	0.54%	0.07%	-0.03%	-0.33%	0.56%	-0.29%	-0.29%	0.27%
EBITDA+	6.47M	3.58M	5.44M	5.77M	5.57M	3.8M	5.81M	4.17M	2.97M	3.74M
EBITDA Margin %	0.46%	0.33%	0.42%	0.42%	0.41%	0.35%	0.42%	0.33%	0.27%	0.31%
EBITDA Growth %	0.14%	-0.45%	0.52%	0.06%	-0.03%	-0.32%	0.53%	-0.28%	-0.29%	0.26%
D&A (Non-Cash Add-back)	173.48K	187.03K	200.68K	191.94K	175.81K	165.26K	145.98K	135.4K	105.68K	95.89K
EBIT	6.29M	3.39M	5.24M	5.58M	5.4M	3.64M	5.67M	4.04M	2.86M	3.65M
Net Interest Income+	0	0	0	0	203.33K	226.25K	233.86K	-1.38M	306.65K	434.68K
Interest Income	0	0	0	0	203.33K	226.25K	233.86K	236.69K	306.65K	434.68K
Interest Expense	0	0	0	227.98K	-	0	0	1.62M	0	0
Other Income/Expense	331.83K	306.5K	315.17K	-113.99K	634.4K	524.83K	210.84K	-809.55K	387.75K	461.67K
Pretax Income+	6.63M	3.7M	5.55M	5.47M	6.03M	4.16M	5.88M	3.23M	3.25M	4.11M
Pretax Margin %	0.47%	0.34%	0.43%	0.4%	0.44%	0.38%	0.42%	0.25%	0.3%	0.34%
Income Tax+	2.02M	1.11M	1.71M	1.11M	1.27M	856.02K	1.22M	658.17K	669.41K	857.58K
Effective Tax Rate %	0.7%	0.7%	0.69%	0.8%	0.79%	0.79%	0.79%	0.8%	0.79%	0.79%
Net Income+	4.61M	2.58M	3.84M	4.35M	4.76M	3.3M	4.66M	2.57M	2.58M	3.25M
Net Margin %	0.33%	0.24%	0.3%	0.32%	0.35%	0.3%	0.33%	0.2%	0.24%	0.27%
Net Income Growth %	0.14%	-0.44%	0.49%	0.13%	0.09%	-0.31%	0.41%	-0.45%	0%	0.26%
Net Income (Continuing)	4.61M	2.58M	3.84M	4.35M	4.76M	3.3M	4.66M	2.57M	2.58M	3.25M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	1.00	0.56	0.84	0.95	1.04	0.72	1.01	0.56	0.56	0.71
EPS Growth %	0.14%	-0.44%	0.5%	0.13%	0.09%	-0.31%	0.4%	-0.45%	0%	0.27%
EPS (Basic)	1.00	0.56	0.84	0.95	1.04	0.72	1.01	0.56	0.56	0.71
Diluted Shares Outstanding	4.59M	4.59M	4.59M	4.58M	4.59M	4.59M	4.59M	4.59M	4.59M	4.59M
Basic Shares Outstanding	4.59M	4.59M	4.59M	4.58M	4.59M	4.59M	4.59M	4.59M	4.59M	4.59M
Dividend Payout Ratio	1%	1.33%	1.69%	1.11%	1.06%	1.08%	1.11%	1.22%	0.18%	0.85%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	14.52M	13.97M	11.85M	11.69M	11.57M	11.25M	11.58M	9.97M	12.25M	12.67M
Cash & Short-Term Investments	11.8M	10.64M	8.45M	8.17M	7.92M	8.18M	8.17M	6.48M	9.09M	9.4M
Cash Only	1.08M	424.3K	724.72K	550.13K	1.05M	591.44K	531.21K	830.45K	8.24M	1.88M
Short-Term Investments	10.72M	10.22M	7.72M	7.62M	6.87M	7.59M	7.64M	5.65M	851.32K	7.52M
Accounts Receivable	934.75K	1.6M	1.91M	1.67M	2.1M	1.39M	1.81M	1.43M	1.57M	1.43M
Days Sales Outstanding	24.36	54.12	53.63	44.34	56.32	46.1	47.52	41.03	52.54	42.8
Inventory	1.29M	1.26M	1.34M	1.48M	1.22M	1.42M	1.41M	1.67M	1.22M	1.45M
Days Inventory Outstanding	90.77	93.88	92.3	95.46	78.54	106.06	89.59	101.78	81.5	92.63
Other Current Assets	329.07K	135.32K	157.96K	159.36K	170.47K	161.21K	0	201.85K	191.71K	207.8K
Total Non-Current Assets+	1.17M	1.15M	1M	857.57K	795.53K	673.66K	658.86K	669.71K	670.13K	1.13M
Property, Plant & Equipment	1.1M	1.09M	942.89K	827.92K	780.71K	673.66K	658.86K	559.16K	619.2K	956.39K
Fixed Asset Turnover	12.78x	9.88x	13.75x	16.63x	17.42x	16.31x	21.14x	22.71x	17.58x	12.74x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	14.82K	0	0	0	0	0
Long-Term Investments	0	0	0	0	-401.68K	0	0	0	0	0
Other Non-Current Assets	-43.89K	-192.84K	-111.7K	-223.94K	14.82K	-151.68K	-83.22K	0	0	0
Total Assets+	15.69M	15.12M	12.85M	12.54M	12.36M	11.92M	12.24M	10.64M	12.92M	13.8M
Asset Turnover	0.89x	0.71x	1.01x	1.10x	1.10x	0.92x	1.14x	1.19x	0.84x	0.88x
Asset Growth %	-0.02%	-0.04%	-0.15%	-0.02%	-0.01%	-0.04%	0.03%	-0.13%	0.21%	0.07%
Total Current Liabilities+	988.37K	1.05M	1.42M	1.37M	1.34M	1.41M	2.34M	1.37M	1.53M	1.91M
Accounts Payable	96.81K	82.82K	354.29K	186.8K	71.39K	31.8K	410.89K	30.41K	134.45K	425K
Days Payables Outstanding	6.79	6.19	24.39	12.03	4.61	2.38	26.09	1.85	8.96	27.11
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	190.16K	0	15.5K	0
Other Current Liabilities	105.93K	215.98K	314.54K	299.25K	373.94K	321.74K	898.4K	638.98K	543.85K	681.73K
Current Ratio	14.69x	13.36x	8.33x	8.55x	8.61x	7.95x	4.95x	7.26x	7.99x	6.62x
Quick Ratio	13.38x	12.15x	7.39x	7.47x	7.71x	6.95x	4.35x	6.04x	7.19x	5.86x
Cash Conversion Cycle	108.33	141.81	121.53	127.76	130.25	149.78	111.01	140.96	125.08	108.32
Total Non-Current Liabilities+	150.39K	252.13K	33.85K	253.58K	386.86K	151.68K	83.22K	0	0	0
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities	118.01K	252.13K	33.85K	253.58K	386.86K	151.68K	83.22K	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	0	0
Total Liabilities	1.14M	1.3M	1.46M	1.62M	1.73M	1.57M	2.42M	1.37M	1.53M	1.91M
Total Debt+	0	0	0	0	0	0	0	0	0	0
Net Debt	-1.08M	-424.3K	-724.72K	-550.13K	-1.05M	-591.44K	-531.21K	-830.45K	-8.24M	-1.88M
Debt / Equity	-	-	-	-	-	-	-	-	-	-
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-0.17x	-0.12x	-0.13x	-0.10x	-0.19x	-0.16x	-0.09x	-0.20x	-2.78x	-0.50x
Interest Coverage	-	-	-	24.48x	-	-	-	2.49x	-	-
Total Equity+	14.55M	13.82M	11.4M	10.92M	10.63M	10.35M	9.82M	9.27M	11.39M	11.88M
Equity Growth %	-0.01%	-0.05%	-0.18%	-0.04%	-0.03%	-0.03%	-0.05%	-0.06%	0.23%	0.04%
Book Value per Share	3.17	3.01	2.48	2.38	2.31	2.25	2.14	2.02	2.48	2.59
Total Shareholders' Equity	14.55M	13.82M	11.4M	10.92M	10.63M	10.35M	9.82M	9.27M	11.39M	11.88M
Common Stock	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K
Retained Earnings	14.02M	13.19M	10.47M	10.47M	10.17M	9.89M	9.36M	8.81M	10.93M	11.42M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	72.36K	175.63K	466.02K	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	5.2M	2.29M	3.99M	4.95M	4.48M	3.59M	5.31M	2.53M	3.14M	3.47M
Operating CF Margin %	0.37%	0.21%	0.31%	0.36%	0.33%	0.33%	0.38%	0.2%	0.29%	0.28%
Operating CF Growth %	0.16%	-0.56%	0.74%	0.24%	-0.1%	-0.2%	0.48%	-0.52%	0.25%	0.1%
Net Income	4.61M	2.58M	3.84M	4.35M	4.76M	3.3M	4.66M	2.57M	2.58M	3.25M
Depreciation & Amortization	173.48K	187.03K	200.68K	191.94K	175.81K	165.26K	145.98K	135.4K	105.68K	95.89K
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	-22.37K	59.71K	-31.76K	219.73K	133.27K	-235.17K	-68.46K	-193.77K	59.61K	-124.47K
Other Non-Cash Items	-21.24K	8.29K	-29.02K	341.65K	-411.79K	-305.75K	14.45K	1.08M	-111.49K	-43.53K
Working Capital Changes	464.68K	-546.75K	8.1K	-155.24K	-182.89K	664.92K	562.77K	-1.06M	509.3K	287.49K
Change in Receivables	679.75K	-671.53K	-311.69K	237.17K	-430.13K	717.87K	-431.88K	385.96K	-135.87K	140.71K
Change in Inventory	-56.49K	37.83K	-84.71K	-141.63K	249.87K	-198.5K	4.98K	-290.22K	465.51K	-214.28K
Change in Payables	-44.3K	-13.99K	271.46K	-167.49K	-115.41K	-39.59K	379.09K	-380.48K	104.03K	290.55K
Cash from Investing+	-1.67M	490.24K	2.82M	-308.76K	1.07M	-468.68K	-183.47K	897.56K	4.73M	-7.08M
Capital Expenditures	-62.57K	-166.69K	-38.15K	-74.99K	-113.77K	-43.4K	-116.38K	-75.18K	-165.72K	-433.08K
CapEx % of Revenue	0%	0.02%	0%	0.01%	0.01%	0%	0.01%	0.01%	0.02%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-60.18K	-167.7K	-4.85K	-70.79K	-113.77K	-43.4K	-116.38K	0	10K	0
Cash from Financing+	-4.47M	-3.44M	-6.51M	-4.82M	-5.05M	-3.58M	-5.19M	-3.12M	-459.39K	-2.76M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-4.59M	-3.44M	-6.51M	-4.82M	-5.05M	-3.58M	-5.19M	-3.12M	-459.39K	-2.76M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	120.85K	0	0	0	0	0	0	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	5.14M	2.12M	3.95M	4.88M	4.36M	3.55M	5.2M	2.45M	2.98M	3.03M
FCF Margin %	0.37%	0.2%	0.3%	0.35%	0.32%	0.32%	0.37%	0.19%	0.27%	0.25%
FCF Growth %	0.16%	-0.59%	0.86%	0.23%	-0.11%	-0.19%	0.46%	-0.53%	0.22%	0.02%
FCF per Share	1.12	0.46	0.86	1.06	0.95	0.77	1.13	0.53	0.65	0.66
FCF Conversion (FCF/Net Income)	1.13x	0.89x	1.04x	1.14x	0.94x	1.09x	1.14x	0.98x	1.22x	1.07x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	1.6M	1.15M	1.1M	1.02M	1.1M	1.13M	600K	1.05M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	31.46%	18.2%	30.49%	39%	44.18%	31.5%	46.18%	26.92%	24.99%	27.94%
Return on Invested Capital (ROIC)	36.06%	18.93%	32.63%	39.77%	40.55%	28.19%	44.62%	34.16%	37.08%	41.59%
Gross Margin	62.86%	54.69%	59.12%	58.84%	58.4%	55.65%	58.74%	52.78%	49.66%	53.03%
Net Margin	32.89%	23.95%	29.64%	31.61%	35.01%	30.08%	33.44%	20.23%	23.71%	26.69%
Interest Coverage	-	-	-	24.48x	-	-	-	2.49x	-	-
FCF Conversion	1.13x	0.89x	1.04x	1.14x	0.94x	1.09x	1.14x	0.98x	1.22x	1.07x
Revenue Growth	4.14%	-23.06%	20.33%	6.18%	-1.24%	-19.21%	26.79%	-8.84%	-14.28%	11.91%

Revenue by Segment

	2012	2013	2014	2015	2016
Personal Care	9.44M	11.46M	9.42M	9.92M	4.92M
Personal Care Growth	-	21.41%	-17.79%	5.32%	-50.45%
Pharmaceuticals	1.52M	916.93K	1.69M	1.86M	3.44M
Pharmaceuticals Growth	-	-39.86%	83.94%	10.53%	84.71%
Medical	2.9M	3.03M	2.49M	2.2M	2.62M
Medical Growth	-	4.28%	-17.65%	-11.64%	19.09%
Industrial And Other	153.5K	164.01K	169.49K	174.36K	159.94K
Industrial And Other Growth	-	6.85%	3.34%	2.88%	-8.27%

Frequently Asked Questions

Valuation & Price

United-Guardian, Inc. (UG) has a price-to-earnings (P/E) ratio of 8.8x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

United-Guardian, Inc. (UG) reported $10.1M in revenue for fiscal year 2024. This represents a 30% decrease from $14.3M in 2011.

United-Guardian, Inc. (UG) grew revenue by 11.9% over the past year. This is steady growth.

Yes, United-Guardian, Inc. (UG) is profitable, generating $2.0M in net income for fiscal year 2024 (26.7% net margin).

Dividend & Returns

Yes, United-Guardian, Inc. (UG) pays a dividend with a yield of 9.58%. This makes it attractive for income-focused investors.

United-Guardian, Inc. (UG) has a return on equity (ROE) of 27.9%. This is excellent, indicating efficient use of shareholder capital.

United-Guardian, Inc. (UG) generated $1.6M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.